Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 39Terminated 12Unknown 8Active not recruiting 7Recruiting 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Gastrointestinal Neoplasms 1Cancer Pain 1Adult Patients Who Are Receiving Oncologic Care 1Adjustment Disorders 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Pharmacogenomic Testing × Clear all
NCT06511401 2026-05-04

C-PAIN

University of Chicago

Phase NA Recruiting
800 enrolled

Adult Patients Who Are Receiving Oncologic Care

NCT06489041 2026-02-02

Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Wake Forest University Health Sciences

Phase NA Recruiting
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT05830279 2025-07-09

Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Recruiting
600 enrolled

Cancer Pain, Adjustment Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡